Greylin Investment Mangement Inc Meridian Bioscience Inc Transaction History

Greylin Investment Mangement Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 14, 2019	SELL	$14.52 - $19.72 $690,934 - $938,376	-47,585 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$14.85 - $16.35 $594,742 - $654,817	-40,050 Reduced 45.7%	47,585 $709,000
Q2 2018 Aug 07, 2018	SELL	$13.8 - $16.8 $21,045 - $25,620	-1,525 Reduced 1.71%	87,635 $1.39 Million
Q1 2018 May 14, 2018	BUY	$13.8 - $16.2 $76,590 - $89,910	5,550 Added 6.64%	89,160 $1.27 Million
Q4 2017 Jan 16, 2018	BUY	$13.55 - $15.8 $152,776 - $178,145	11,275 Added 15.59%	83,610 $1.17 Million
Q3 2017 Nov 14, 2017	BUY	$13.45 - $14.35 $972,905 - $1.04 Million	72,335	72,335 $1.03 Million

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Greylin Investment Mangement Inc, based on Form 13F filings with the SEC.

Stay updated on Greylin Investment Mangement Inc with notifications on news.